Gregg W. Stone
Elite in Heart Bypass Surgery
Check Dr. Gregg W. Stone's experience treating your condition:
About Dr. Gregg W. Stone

Gregg Stone is a Cardiologist and an Interventional Cardiologist in New York, New York. Stone has been practicing medicine for over 40 years and is rated as an Elite expert by MediFind in Heart Bypass Surgery. He is also highly rated in 29 other conditions, according to our data. His top areas of expertise are Coronary Heart Disease, Heart Attack, Mitral Valve Regurgitation, Percutaneous Coronary Intervention (PCI), and Angioplasty. He is licensed to treat patients in New York.

His clinical research consists of co-authoring 1208 peer reviewed articles and participating in 27 clinical trials in the past 15 years. In particular, he has co-authored 187 articles and participated in 1 clinical trial in the study of Heart Bypass Surgery.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Gregg W. Stone it is best to call his office and ask if your insurance is accepted.

Call to see if your plan is accepted.
161 Fort Washington Ave, New York, NY 10032
Background & Education
Graduate Institution
Johns Hopkins University School Of Medicine, 1982
Interventional Cardiology
Internal Medicine in NY
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

25 Clinical Trials

Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Clinical Study of the BioVentrix Revivent TC™ System for Treatment of Left Ventricular Aneurysms (ALIVE)
RELIEVE-HF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Post-Myocardial Infarction Remodeling Prevention Therapy
TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent
Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization.
The Preventive Coronary Intervention on Stenosis With Functionally Insignificant Stenosis With Vulnerable Plaque Characteristics
Randomized Trial Of Hybrid Coronary Revascularization Versus Percutaneous Coronary Intervention
A Prospective, Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
COOL RCN: Cooling to Prevent Radiocontrast Nephropathy in Patients Undergoing Diagnostic or Interventional Catheterization
Coronary Orbital Atherectomy System Study
SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
EXCEL Clinical Trial (Universal Registry)
TAXUS V: De Novo Lesion: A Randomized, Double-blind Trial to Assess TAXUS Paclitaxel-Eluting Coronary Stents, SR Formulation, in the Treatment of De Novo Coronary Lesions
VELOCITY: Pilot Study to Evaluate Ultrafast Hypothermia Before Reperfusion in Patients With Acute ST-Elevation Myocardial Infarction
SPIRIT III: A Clinical Evaluation of the Investigational Device XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
View 22 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors